{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:12:46Z","timestamp":1751429566877,"version":"3.41.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Clinical guidelines recommend use of (1) antiplatelet, (2) lipid-lowering, and (3) beta blocker medication, and (4) angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEi\/ARB) for secondary prevention following myocardial infarction (MI). This study examines whether sociodemographic factors and comorbidity were associated with receipt of guideline-recommended medication, and whether receipt was associated with all-cause mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cohort study was conducted on West of Scotland patients aged 53\u00a0years or above who were discharged from hospital alive after an incident MI between 2014 and 2022. Receipt of guideline-directed therapy was defined as relevant medications dispensed within 3\u00a0months of discharge. Age, sex, area-deprivation, care\/nursing home residence, year of incident MI, and pre-existing conditions were included as predictors of non-receipt and covariates in the analysis of the association between non-receipt and death.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 12,204 MI survivors, 7898 (64.72%) received all four classes of recommended medications. Non-receipt increased over the study period and was more likely in women, older people, more deprived people, care\/nursing home residents, or those with preexisting atrial fibrillation, chronic kidney disease, liver diseases, chronic obstructive pulmonary disease, or psychosis; and was less likely in those who had prior revascularisation. Non-receipt was associated with higher mortality (HR 1.15, 95% CI 1.05\u20131.26) after adjusting for sociodemographic factors and preexisting conditions. Excess mortality due to area deprivation and care\/nursing home residence could be partly explained by non-receipt of ACEi\/ARB (9.4% for deprivation; 40.7% for care\/nursing home residence) and lipid lowering medication (39.7% for care\/nursing home residence).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Recommended secondary prevention medications were less likely to be received by women, those deprived, living in care\/nursing homes, and with comorbid conditions. Equivalising appropriate ACEi\/ARB use for secondary prevention could slightly reduce socioeconomic inequality of cardiovascular mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-04160-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:41:38Z","timestamp":1751373698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of sociodemographic factors and comorbidity with non-receipt of medications for secondary prevention: a cohort study of 12,204 myocardial infarction survivors"],"prefix":"10.1186","volume":"23","author":[{"given":"Ike Dhiah","family":"Rochmawati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn M.","family":"Friday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Q. B.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clea","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Lewsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Dundas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhautesh","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Vittal","family":"Katikireddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Celis-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4160_CR1","doi-asserted-by":"crossref","unstructured":"Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36:1163\u201370.","DOI":"10.1093\/eurheartj\/ehu505"},{"issue":"5","key":"4160_CR2","first-page":"369","volume":"16","author":"F Massimo","year":"2016","unstructured":"Massimo F, Piepoli UC. Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur J Cardiovasc Nurs. 2016;16(5):369\u201380.","journal-title":"Eur J Cardiovasc Nurs."},{"issue":"44","key":"4160_CR3","first-page":"3720","volume":"2023","author":"A Robert","year":"2023","unstructured":"Robert A, Byrne XR, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan G-A, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, J\u00fcni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Gimenez MR, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B. ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;2023(44):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"148","key":"4160_CR4","first-page":"e9","volume":"2023","author":"S Salim","year":"2023","unstructured":"Salim S, Virani LKN, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS. AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;2023(148):e9\u2013119.","journal-title":"Circulation"},{"key":"4160_CR5","unstructured":"Excellence NIfHaC. Acute Coronary Syndromes: NICE guideline (NG185).\u00a02020.\u00a0https:\/\/www.niceorguk\/guidance\/ng185.\u00a0Accessed 13 July 2024."},{"issue":"3227","key":"4160_CR6","first-page":"337","volume":"42","author":"Frank L.J. Visseren","year":"2012","unstructured":"Frank L.J. Visseren*, Franc\u00b8ois Mach* YMS, David Carballo, Konstantinos C. Koskinas, Maria B\u20acack, Athanase Benetos AB, Jose\u00b4-Manuel Boavida, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H. Davos, Ileana Desormais, Emanuele Di Angelantonio OHF, Sigrun, Halvorsen FDRH, Monika Hollander, Ewa A. Jankowska, Matthias Michal, Simona, Sacco0 NS, Lale Tokgozoglu et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(3227):337.","journal-title":"Eur Heart J"},{"key":"4160_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"Sayed H. Naderi JPB","year":"2012","unstructured":"Sayed H. Naderi JPB, David S. Wald. Adherence to Drugs That Prevent Cardiovascular Disease: Meta analysis on 376,162 Patients. Am J Med. 2012;125:882\u20137.","journal-title":"Am J Med"},{"key":"4160_CR8","doi-asserted-by":"crossref","unstructured":"Niels P. G. Hoedemaker Peter Damman JPO, Jan Henk E. Dambrink, A. T. Marcel Gosselink, Elvin Kedhi, Evelien Kolkman, Robbert J. de Winter, ArnoudW. J. van \u2019t Ho. Trends in optimalmedical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting. Eur Heart J Cardiovasc Pharmacother. 2018;4:102\u201310.","DOI":"10.1093\/ehjcvp\/pvy005"},{"key":"4160_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/HJR.0b013e328338e5da","volume":"17","author":"AKGT Bauer","year":"2010","unstructured":"Bauer AKGT, Ju\u00a8nger C, Zahn R, Koeth O, Towae F, Schwarz AK, Bestehorn K, Zeymer JSU. For the Acute Coronary Syndromes Registry (ACOS) investigators, on behalf of the J-MINUET. Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence. Eur J Cardiovasc Prev Rehabil. 2010;17:576\u201381.","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"4160_CR10","unstructured":"Joint Formulary Committee. British National Formulary (online) London: BMJ and Pharmaceutical Press. http:\/\/www.medicinescomplete.com. Accessed 29 Apr 2024."},{"key":"4160_CR11","doi-asserted-by":"crossref","unstructured":"Salpeter SR OT, Salpeter EE. Cardioselective beta-blockers for chronic obstructive pulmonary disease (Review). Cochrane Database of Systematic Reviews. 2005;Issue 4. Art. No.: CD003566.","DOI":"10.1002\/14651858.CD003566.pub2"},{"issue":"No.3","key":"4160_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ije\/dyw060","volume":"45","author":"Samantha Alvarez-Madrazo SM","year":"2016","unstructured":"Samantha Alvarez-Madrazo SM, Clifford Nangle, Elizabeth Nicholson, Marion Bennie. Data Resource Profile: The Scottish National Prescribing Information System (PIS). Int J Epidemiol. 2016;45(No.3):714\u20135f.","journal-title":"Int J Epidemiol"},{"key":"4160_CR13","doi-asserted-by":"crossref","unstructured":"Frank L.J. Visseren FoM, Yvo M. Smulders, Smulders, Konstantinos C. Koskinas, Maria B\u20acack, Athanase Benetos, Alessandro Biffi, Jose\u00b4-Manuel Boavida, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H. Davos, Ileana Desormais, Emanuele Di Angelantonio, Oscar H. Franco, Sigrun Halvorsen, F.D. Richard Hobbs, Monika Hollander, Ewa A. Jankowska, Matthias Michal, Simona Sacco, Naveed Sattar, Lale Tokgozoglu, Serena Tonstad, Konstantinos P. Tsioufis, Ineke van Dis, Isabelle C. van Gelder, ChristophWanner, BryanWilliams. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021;42:3227-337.","DOI":"10.1093\/eurheartj\/ehab484"},{"issue":"l5657","key":"4160_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.l5657","volume":"367","author":"RJ Desai","year":"2019","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367(l5657):1\u201310. https:\/\/doi.org\/10.1136\/bmj.l5657. PMID: 31645336.","journal-title":"BMJ"},{"issue":"4","key":"4160_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/EDE.0000000000000311","volume":"26","author":"M Moreno-Betancur","year":"2015","unstructured":"Moreno-Betancur M, Latouche A, Menvielle G, Kunst AE, Rey G. Relative index of inequality and slope index of inequality: a structured regression framework for estimation. Epidemiology. 2015;26(4):518\u201327. https:\/\/doi.org\/10.1097\/EDE.0000000000000311. PMID: 26000548.","journal-title":"Epidemiology"},{"key":"4160_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/EDE.0000000000000595","volume":"28","author":"Rishi J. Desai KJR","year":"2017","unstructured":"Rishi J. Desai KJR, Brian T. Bateman, Sonia Hernandez-Diaz, Krista F. Huybrechts. A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent. Epidemiology. 2017;28:249\u201357.","journal-title":"Epidemiology"},{"key":"4160_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/EDE.0000000000000121","volume":"25","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele TJ. A Unification of Mediation and Interaction: A 4-Way Decomposition. Epidemiology. 2014;25:749\u201361.","journal-title":"Epidemiology"},{"key":"4160_CR18","doi-asserted-by":"publisher","first-page":"e014415","DOI":"10.1161\/JAHA.119.014415","volume":"9","author":"Matthew D. Solomon TKL","year":"2020","unstructured":"Matthew D. Solomon TKL, Eleanor Levin, Jamal S. Rana, Marc G. Jaffe, Stephen Sidney, Sue Hee Sung, Catherine Lee, Anthony DeMaria, Alan S.Go. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Association. 2020;9:e014415.","journal-title":"J Am Heart Association"},{"key":"4160_CR19","doi-asserted-by":"publisher","first-page":"e042886","DOI":"10.1136\/bmjopen-2020-042886","volume":"10","author":"Julia Frank-Tewaag JB","year":"2020","unstructured":"Julia Frank-Tewaag JB, Dirk Horenkamp-Sonntag, Ursula Marschall, Uwe Zeymer, Norbert Donner-Banzhoff, Leonie Sundmacher. Use of guideline-recommended drug therapy in patients undergoing percutaneous coronary intervention for\u00a0stable coronary heart disease in Germany a multilevel analysis of nationwide routine data. BMJ Open. 2020;10:e042886.","journal-title":"BMJ Open"},{"key":"4160_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/ehjqcco\/qcab007","volume":"8","author":"Misha Dagan DTD","year":"2022","unstructured":"Misha Dagan DTD, Julia Stehli, Christianne Tan, Angela Brennan, Josephine Warren, Andrew E. Ajani, Melanie Freeman, Alexandra Murphy, Christopher M. Reid, Chin Hiew, Ernesto Oqueli, David J. Clark, Stephen J. Duffy. Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome. Eur Heart J Qual Care Clin Outcomes. 2022;8:420\u20138.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"3","key":"4160_CR21","doi-asserted-by":"publisher","first-page":"E112","DOI":"10.1002\/ccd.27860","volume":"93","author":"Z Ge","year":"2019","unstructured":"Ge Z, Baber U, Claessen BE, Farhan S, Chandrasekhar J, Li SX, et al. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Catheter Cardiovasc Interv. 2019;93(3):E112\u20139.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"4160_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/2047487312462148","volume":"21","author":"DGBA Buja","year":"2014","unstructured":"Buja DGBA, Furlan P, Bertoncello C, Casale P, Baldovin T, Marcolongo A, Baldo V. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities? European Journal of Preventive Cardiology. 2014;21(2):222\u201330.","journal-title":"European Journal of Preventive Cardiology."},{"issue":"11","key":"4160_CR23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1177\/2047487313494580","volume":"21","author":"Marta Pereira CAj","year":"2014","unstructured":"Marta Pereira CAj, Paula Dias, Nuno Lunet, Isaac Subirana JM, Simon Capewell, Kathleen Bennett AA. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study. Eur J Prev Cardiol. 2014;21(11):1401\u20138.","journal-title":"Eur J Prev Cardiol"},{"key":"4160_CR24","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1111\/jgs.15144","volume":"65","author":"Andrew R. Zullo SS","year":"2017","unstructured":"Andrew R. Zullo SS, Yoojin Lee, Lori A. Daiello, Nishant R. Shah, W. John Boscardin, David D. Dore, Sei J. Lee, Michael A. Steinman. Secondary Prevention Medication Use After Myocardial\u00a0Infarction in U.S. Nursing Home Residents. J Am Geriatr Soc. 2017;65:2397\u2013404.","journal-title":"J Am Geriatr Soc"},{"key":"4160_CR25","doi-asserted-by":"crossref","unstructured":"Andrew R. Zullo AM, Katherine Corsi, Nishant R. Shah, Sei J. Lee, James L. Rudolph,, Wen-Chih Wu RD-A, Christine Berard-Collins, Michael A. Steinman. Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2019;12:e004942.","DOI":"10.1161\/CIRCOUTCOMES.118.004942"},{"issue":"10","key":"4160_CR26","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","volume":"86","author":"AC Drenth-van Maanen","year":"2020","unstructured":"Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921\u201330. https:\/\/doi.org\/10.1111\/bcp.14094.","journal-title":"Br J Clin Pharmacol."},{"key":"4160_CR27","doi-asserted-by":"crossref","unstructured":"Denis O\u2019Mahony AC, Anna Renom Guiteras, Michael Denkinger, Jean\u2011Baptiste Beuscart,, Graziano Onder AG, Alfonso J. Cruz\u2011Jentoft, Wilma Knol, G\u00fclistan Bahat,, Nathalie van der Velde MP, Denis Curtin. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14:625\u20133.","DOI":"10.1007\/s41999-023-00777-y"},{"issue":"1","key":"4160_CR28","doi-asserted-by":"publisher","first-page":"102157:1-11","DOI":"10.1016\/j.aprim.2021.102157","volume":"54","author":"G Sotorra-Figuerola","year":"2022","unstructured":"Sotorra-Figuerola G, Ouchi D, Garc\u00eda-Sangen\u00eds A, Giner-Soriano M, Morros R. Pharmacological treatment after acute coronary syndrome: Baseline clinical characteristics and gender differences in a population-based cohort study. Aten Primaria. 2022;54(1):102157:1-11. https:\/\/doi.org\/10.1016\/j.aprim.2021.102157.","journal-title":"Aten Primaria."},{"key":"4160_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/heartjnl-2018-313959","volume":"105","author":"OBC Wilkinson","year":"2019","unstructured":"Wilkinson OBC, Dondo TB, Munyombwe T, Casadei B, Clarke S, Schiele F, Timmis A, Hall M, Gale CP. Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study. Heart. 2019;105:516\u201323.","journal-title":"Heart."},{"key":"4160_CR30","doi-asserted-by":"crossref","unstructured":"Bj\u20acorn Redfors OA, Truls Ramunddal, Petur Petursson, Inger Haraldsson, Christian Dworeck, Jacob Odenstedt, Dan Ioaness, Annika Ravn-Fischer, Peder Wellin, Helen Sj\u20acoland, Lale Tokgozoglu, Hans Tygesen, Erik Frick, Rickard Roupe, Per Albertsson, Elmir Omerovic. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies\u00a0(SWEDEHEART). J Am Heart Assoc. 2015;4:e001995.","DOI":"10.1161\/JAHA.115.001995"},{"key":"4160_CR31","doi-asserted-by":"crossref","unstructured":"George Mnatzaganian CMYL, Suzanne Robinson, Freddy Sitas, Clara K. Chow,MarkWoodward, Rachel R. Huxley. Socioeconomic disparities in themanagement of coronary heart disease in 438 general practices in Australia. Eur J Prev Cardiol. 2021;28:400\u20137.","DOI":"10.1177\/2047487320912087"},{"issue":"100141","key":"4160_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lanepe.2021.100141","volume":"7","author":"ASV Shah","year":"2021","unstructured":"Shah ASV, Lee KK, P\u00e9rez JAR, Campbell D, Astengo F, Logue J, Gallacher PJ, Katikireddi SV, Bing R, Alam SR, Anand A, Sudlow C, Fischbacher CM, Lewsey J, Perel P, Newby DE, Mills NL, McAllister DA. Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study. Lancet Reg Health Eur. 2021;7(100141):1\u20139. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100141.","journal-title":"Lancet Reg Health Eur"},{"key":"4160_CR33","doi-asserted-by":"crossref","unstructured":"Min Zhao MW, Ilonca Vaartjes, Elizabeth R. C. Millett, Kerstin Klipstein-Grobusch, Karice Hyun, Cheryl Carcel, Sanne A. E. Peters. Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2020;9:e014742.","DOI":"10.1161\/JAHA.119.014742"},{"issue":"8","key":"4160_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1177\/2048872620902024","volume":"9","author":"MO Hideki Wada","year":"2020","unstructured":"Hideki Wada MO, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M. Guideline adherence and longterm clinical outcomes in patients with acute myocardial infarction a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy. Eur Heart J Acute Cardiovasc Care. 2020;9(8):939\u201347.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"4160_CR35","doi-asserted-by":"crossref","unstructured":"Engelbertz C, Feld J, Makowski L, Kuhnemund L, Fischer AJ, Lange SA, et al. Contemporary in-hospital and long-term prognosis of patients with acute ST-elevation myocardial infarction depending on renal function: a retrospective analysis. BMC Cardiovasc Disorders. 2023;23(1) (no pagination).","DOI":"10.1186\/s12872-023-03084-3"},{"key":"4160_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003626","volume":"5","author":"WN Paulette Wehner","year":"2016","unstructured":"Paulette Wehner WN. Chronic Kidney Disease and Acute Myocardial Infarction: The Story After 1 Year. J Am Heart Assoc. 2016;5: e003626.","journal-title":"J Am Heart Assoc"},{"key":"4160_CR37","doi-asserted-by":"crossref","unstructured":"Volker M. Lauschke MI-S. The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity. Int J Mol Sci. 2016;17:1714.","DOI":"10.3390\/ijms17101714"},{"key":"4160_CR38","doi-asserted-by":"crossref","unstructured":"Ting-Yun Lin T-HH, Szu-Chun Hung. Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients. Clin Kidney J. 2022;15(no.11):2135\u201343.","DOI":"10.1093\/ckj\/sfac170"},{"key":"4160_CR39","doi-asserted-by":"crossref","unstructured":"Sungho Bea I-SO, Ju Hwan Kim, Dong Hyun Sinn, Yoosoo Chang, Seungho Ryu, Ju-Young Shin. High-Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population-Based Cohort Study. J Am Heart Assoc. 2023;12:e028310.","DOI":"10.1161\/JAHA.122.028310"},{"key":"4160_CR40","doi-asserted-by":"crossref","unstructured":"Xinfang Xie YL, Vlado Perkovic, Xiangling Li, , Toshiharu Ninomiya WH, Na Zhao, Lijun Liu, Jicheng Lv, Hong Zhang, Haiyan Wang. Renin-Angiotensin System Inhibitors and Kidney and\u00a0Cardiovascular Outcomes in Patients With CKD. A Bayesian Network Meta-analysis of Randomized Clinical Trials. Am J Kidney Dis. 2016;67(5):728\u201341.","DOI":"10.1053\/j.ajkd.2015.10.011"},{"key":"4160_CR41","doi-asserted-by":"crossref","unstructured":"Wai Hoong Chang SHM, Yen Yi Tan, Alvina G. Lai. Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding. Lancet Reg Health Eur. 2021;10:100222.","DOI":"10.1016\/j.lanepe.2021.100222"},{"key":"4160_CR42","doi-asserted-by":"crossref","unstructured":"S-WCV Chien-ChiaWu , C An-Hsun, T Pei-Chi, C Chih-Hsiang, M Wu, H Ming-Jer, W Chao-Yung, C Shang-Hung, LKCH Ming-Shyan, H I-Chang, C Pao-Hsien, W Cheng-Shyong, L Yu-Sheng. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction \u2013 A 13-year nationwide cohort study. Plos One. 2019;14(10):e0223380.","DOI":"10.1371\/journal.pone.0223380"},{"key":"4160_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apt.17297","volume":"57","author":"Jiayi Ma NPC","year":"2023","unstructured":"Jiayi Ma NPC, Linus Schwantes-An, Einar Stef\u00e1n Bj\u00f6rnsson. Review article: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis. Alliment Pharmacol Ther. 2023;57:52\u201371.","journal-title":"Alliment Pharmacol Ther"},{"key":"4160_CR44","doi-asserted-by":"crossref","unstructured":"JKNCWC Chang, CSM Wong, JSH Hai, PCF Or, EH Chen. Mortality revascularization and cardioprotective pharmacotherapy after acute coronary syndrome in patients with psychotic disorders a population-based cohort study. Schizophrenia Bulletin. 2020;46(no4):774\u201384.","DOI":"10.1093\/schbul\/sbaa013"},{"issue":"109737","key":"4160_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2019.109737","volume":"96","author":"M Shao","year":"2020","unstructured":"Shao M, Tian H, Wang L, Jiang D, Ji F, Zhuo C. Mortality risk following acute coronary syndrome among patients with schizophrenia: A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96(109737):1\u20137. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109737.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4160_CR46","first-page":"9","volume":"178","author":"JF Marco Solmi","year":"2021","unstructured":"Marco Solmi JF, Laura Poddighe, Marco Delogu, Alessandro Miola, Anne H\u00f8ye, Ina H. Heiberg, Brendon Stubbs, Lee Smith, Henrik Larsson, Rubina Attar, Renee E. Nielsen, Samuele Cortese, Jae Il Shin, Paolo Fusar-Poli, Joseph Firth, Lakshmi N. Yatham, Andre F. Carvalho, David J. Castle, Mary V. Seeman, Christoph U. Correll. Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies. Am J Psychiatry. 2021;178:9.","journal-title":"Am J Psychiatry"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04160-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04160-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04160-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:41:43Z","timestamp":1751373703000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04160-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4160"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04160-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data extraction and record linkage were performed by the West of Scotland Safe Haven service (IRAS Project ID 321198) at NHS Greater Glasgow and Clyde, under local ethical approval GSH22ME007.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"381"}}